Matsudo City General Hospital
Matsudo, Chiba, Japan
Government hospital in Matsudo
993-1 Sendabori, Matsudo, Chiba 270-2252
About Matsudo City General Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
2
Janssen Research & Development, LLC
2
Chiba University
1
Eli Lilly and Company
1
Pfizer
1
Clinical Trials at Matsudo City General Hospital
During the past decade, Matsudo City General Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
2013-06-27
2020-11-12
Completed
2,877
Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee
2015-07-21
2019-02-27
Completed
3,021
A Study to Evaluate the Safety and Efficacy of Intravenous JNJ-64179375 Versus Oral Apixaban in Participants Undergoing Elective Total Knee Replacement Surgery
2017-11-13
2018-11-05
Completed
308
Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4)
2018-01-24
2021-06-30
Terminated
103
Assessment of Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
2018-10-27
2019-12-25
Withdrawn
0
A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery
2019-06-17
2021-04-06
Completed
1,242
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Matsudo City General Hospital" #1 sponsor was "Bayer" with 2 trials, followed by "Janssen Research & Development, LLC" with 2 trials
sponsored, "Chiba University" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Pfizer"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Matsudo City General Hospital"
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Matsudo City General Hospital
According to Clinical.Site data, the most researched conditions in "Matsudo City General Hospital" are
"Uterine Fibroids" (2 trials), "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis" (1 trials), "Arthroplasty, Replacement, Knee" (1 trials), "Chronic Pain" (1 trials) and "Microscopic Polyangiitis" (1 trials). Many other conditions were trialed in "Matsudo City General Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Matsudo City General Hospital
Most popular intervention types in "Matsudo City General Hospital" are "Drug" (7 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Vilaprisan (BAY1002670)" (2 trials), "Apixaban 2.5 mg" (1 trials), "Apixaban placebo" (1 trials) and "Baricitinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Matsudo City General Hospital
The vast majority of trials in "Matsudo City General Hospital" are
5 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Matsudo City General Hospital
Currently, there are NaN active trials in "Matsudo City General Hospital".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Matsudo City General Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Matsudo City General Hospital, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".